CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
Public ClinicalTrials.gov record NCT00968812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the efficacy, safety, and tolerability of canagliflozin (JNJ-28431754) compared with glimepiride in patients with type 2 diabetes mellitus with inadequate control despite treatment with metformin.
Study identification
- NCT ID
- NCT00968812
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,452 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2009
- Primary completion
- Nov 30, 2011
- Completion
- Dec 31, 2012
- Last update posted
- Jan 29, 2017
2009 – 2013
United States locations
- U.S. sites
- 43
- U.S. states
- 22
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Calera | Alabama | — | — |
| Not listed | Gilbert | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Encinitas | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Lincoln | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Chipley | Florida | — | — |
| Not listed | Marianna | Florida | — | — |
| Not listed | Oldsmar | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Perry | Georgia | — | — |
| Not listed | Nampa | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Vernon Hills | Illinois | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Bloomfield Hills | Michigan | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Canal Fulton | Ohio | — | — |
| Not listed | Gallipolis | Ohio | — | — |
| Not listed | Mason | Ohio | — | — |
| Not listed | Perrysburg | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Yukon | Oklahoma | — | — |
| Not listed | Fleetwood | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | Pearland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Olympia | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
| Not listed | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00968812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00968812 live on ClinicalTrials.gov.